| Primary |
| Gastrooesophageal Reflux Disease |
14.3% |
| Gastric Ulcer |
8.2% |
| Hypertension |
8.2% |
| Pneumonia |
8.2% |
| Metabolic Disorder |
6.1% |
| Oedema |
6.1% |
| Oesophageal Disorder |
6.1% |
| Pulmonary Embolism |
6.1% |
| Dyspepsia |
4.1% |
| Essential Hypertension |
4.1% |
| Hormone Replacement Therapy |
4.1% |
| Migraine |
4.1% |
| Tremor |
4.1% |
| Ulcer Haemorrhage |
4.1% |
| Acne |
2.0% |
| Alcohol Abuse |
2.0% |
| Asthma |
2.0% |
| Constipation |
2.0% |
| Convulsion |
2.0% |
| Depression |
2.0% |
|
| Gastric Polyps |
8.3% |
| Intestinal Functional Disorder |
8.3% |
| Pancytopenia |
8.3% |
| Wheezing |
8.3% |
| Alopecia |
4.2% |
| Arrhythmia |
4.2% |
| Delirium |
4.2% |
| Dysgeusia |
4.2% |
| Eye Haemorrhage |
4.2% |
| Hepatic Cirrhosis |
4.2% |
| Hepatitis C |
4.2% |
| Hypersensitivity |
4.2% |
| Hypomagnesaemia |
4.2% |
| Hypoventilation |
4.2% |
| Liver Function Test Abnormal |
4.2% |
| Malaise |
4.2% |
| Musculoskeletal Pain |
4.2% |
| Myalgia |
4.2% |
| Pharyngeal Oedema |
4.2% |
| Pneumonia |
4.2% |
|
| Secondary |
| Product Used For Unknown Indication |
20.4% |
| Drug Use For Unknown Indication |
16.7% |
| Hodgkin's Disease |
8.0% |
| Cholangitis |
7.4% |
| Peptic Ulcer |
4.9% |
| Pruritus |
4.9% |
| Vomiting |
4.9% |
| Pain |
4.3% |
| Pulmonary Embolism |
3.7% |
| Gastroenteritis |
3.1% |
| Cholelithiasis |
2.5% |
| Depression |
2.5% |
| Hypotension |
2.5% |
| Pneumonia |
2.5% |
| Thrombosis Prophylaxis |
2.5% |
| Acne |
1.9% |
| Asthma |
1.9% |
| Gastric Ulcer |
1.9% |
| Gastritis |
1.9% |
| Hypertension |
1.9% |
|
| Toxic Epidermal Necrolysis |
18.5% |
| Liver Function Test Abnormal |
7.4% |
| Tubulointerstitial Nephritis |
7.4% |
| White Blood Cell Count Increased |
7.4% |
| Alanine Aminotransferase Increased |
3.7% |
| Bone Marrow Failure |
3.7% |
| Cerebrovascular Accident |
3.7% |
| Dysgeusia |
3.7% |
| Hypomagnesaemia |
3.7% |
| Myoglobin Blood Increased |
3.7% |
| Neutropenic Infection |
3.7% |
| Pancreatitis Chronic |
3.7% |
| Pancytopenia |
3.7% |
| Peripheral Sensory Neuropathy |
3.7% |
| Pleural Effusion |
3.7% |
| Pneumonia |
3.7% |
| Protein Urine |
3.7% |
| Pyrexia |
3.7% |
| Tinnitus |
3.7% |
| Tongue Haemorrhage |
3.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
33.9% |
| Product Used For Unknown Indication |
14.0% |
| Diffuse Large B-cell Lymphoma |
9.9% |
| Hypertension |
5.7% |
| Pain |
4.5% |
| Prophylaxis |
4.4% |
| Colorectal Cancer |
3.6% |
| Rheumatoid Arthritis |
2.8% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Hiv Infection |
2.3% |
| Osteoporosis |
2.2% |
| Depression |
2.2% |
| Multiple Myeloma |
1.9% |
| Atrial Fibrillation |
1.9% |
| Type 2 Diabetes Mellitus |
1.5% |
| Constipation |
1.5% |
| Asthma |
1.4% |
| Diabetes Mellitus |
1.4% |
| Nausea |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
|
| Vomiting |
12.9% |
| Pneumonia |
8.0% |
| Pulmonary Embolism |
8.0% |
| Polyarthritis |
6.1% |
| Gastrointestinal Haemorrhage |
5.5% |
| Myocardial Infarction |
4.9% |
| Transient Ischaemic Attack |
4.9% |
| Weight Decreased |
4.9% |
| Blood Immunoglobulin M Decreased |
4.3% |
| Renal Impairment |
4.3% |
| Sepsis |
4.3% |
| Ascites |
3.7% |
| Pyrexia |
3.7% |
| Renal Failure |
3.7% |
| Tachycardia |
3.7% |
| Tremor |
3.7% |
| Urticaria |
3.7% |
| Visual Impairment |
3.7% |
| Death |
3.1% |
| Gastric Perforation |
3.1% |
|
| Interacting |
| Gastritis |
47.1% |
| Hypertension |
23.5% |
| Hypovitaminosis |
23.5% |
| Chronic Myeloid Leukaemia |
5.9% |
|
| Vision Blurred |
80.0% |
| Drug Interaction |
20.0% |
|
